All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Other | 2005-003318-13 | A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following surgery for biliary tract cancer. | not-yet-due | |
Completed, but no date, and reported results Terminated | 2005-005164-83 | A PHASE 2 STUDY OF CARBOPLATIN IN COMBINATION WITH GEMCITABINE AS A DOSE DENSE SCHEDULE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER THAT ARE RESISTANT TO ANTHRACYCLINES & TAXANES. | bad-data | |
Reported results | 2006-005740-83 | A Pragmatic Randomised Trial of Ibuprofen, Paracetamol, Steam and Delayed Prescribing for Patients with Respiratory Tract Infections in Primary Care | 2012-03-12 | due-trials |
Reported results | 2007-001586-15 | (GRACE Antibiotic Trial One GRACE AT ONE | 2011-04-05 | due-trials |
Completed, but no date, and reported results | 2008-006435-13 | GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).Workpackage 10: Antibiotic Trial One | bad-data | |
Reported results | 2009-013400-31 | A phase 2, double-blind, placebo-controlled study of the safety and tolerability of etanercept in patients with Alzheimer’s disease | 2013-08-30 | due-trials |
Reported results | 2009-013426-16 | Management of Irritable Bowel Syndrome in Primary Care: Feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy webs... | 2011-10-01 | due-trials |
Reported results | 2011-004910-41 | A Randomised Controlled Trial to assess a food supplement (baker’s yeast extract) to support immune function and prevent cold and flu symptoms in a 50 to 70 year old population | 2012-04-30 | due-trials |
Other | 2012-001779-35 | The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder | not-yet-due | |
Reported results | 2013-003327-11 | Alternative Treatments of Adult female Urinary Tract Infection: a double blind, placebo controlled,factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen. | 2017-10-21 | due-trials |
Reported results | 2013-004589-32 | Bath Additives for the Treatment of cHildhood Eczema (BATHE) | 2018-03-01 | due-trials |
Reported results Terminated | 2015-002145-63 | A double-blind, placebo-controlled study of the effect of a TNF alpha inhibitor, etanercept (Enbrel), on microglial activation in amyloid PET positive patients with Mild Cognitive Impairment due to AD... | 2018-04-03 | due-trials |
Reported results | 2015-002455-97 | Antibiotics for lower Respiratory Tract Infection in Children presenting in Primary Care | 2020-04-17 | due-trials |
Other | 2016-003111-35 | CheckpOiNt blockade For Inhibition of Relapsed Mesothelioma (CONFIRM): A Phase III Trial to Evaluate the Efficacy of Nivolumab in Relapsed Mesothelioma | not-yet-due | |
Other | 2018-000644-26 | Aspirin To Target Arterial events in Chronic Kidney Disease | not-yet-due | |
Other | 2018-003630-33 | Spironolactone for Adult Female Acne: A pragmatic multicentre double-blind randomised superiority trial to investigate the clinical and cost-effectiveness of spironolactone for moderate or severe pers... | not-yet-due |